TALAPRO-2 Patient Summary This trial is for patients with metastatic Castration-Resistant Prostate Cancer who have not received prior treatment for Castrate-Resistant disease. More information and to check your eligibility for this trial:
PHEN Contact: 617-481-4020
Go Back |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |